Bioceres Crop Solutions
Commercializes seed, microbial, nutrition, and crop-protection products for agricultural production.
Something off on this page? Send us feedback.
Profile
Commercializes seed traits, microbial agricultural inputs, crop-nutrition products, and crop-protection products. An Argentine grower-founded platform, it now focuses its continuing operations on Crop Protection, Crop Nutrition, and Seed and Integrated Products.
Commercializes seed traits, microbial agricultural inputs, and crop-input products from an Argentina-centered operating base. The portfolio includes patented seed and microbial technologies and the HB4 program's digital and traceability tools.
Founded in Argentina by farmers and agronomists, the platform expanded its product lines through the controlling Rizobacter acquisition. Its business lines are Seed and Integrated Products, Crop Protection, and Crop Nutrition.
The current continuing business now excludes the foreclosed Pro Farm activities in the United States and Europe. Its current structure remains shaped by that discontinuation and an Argentina-centered focus.
Company facts
Key statistics
Year to date −69.3% · Average volume (30d) 165.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Canaccord Genuity | Reiterate | Hold | $2.50 | $2 | |
| Sep 10, 2025 | Lake Street | Reiterate | Buy | $13 | $5 | |
| Sep 10, 2025 | Canaccord Genuity | Downgrade | Buy | Hold | $12.50 | $2.50 |
| Sep 9, 2025 | Oppenheimer | Target | $13 | $5 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| May 11, 2026Q3 FY26 | −$0.05 | −$0.16 | −220.0% | $54.5M | $39.4M | −27.7% | −16.94% |
| Mar 13, 2026Q2 FY26 | $0.07 | −$0.08 | −214.3% | $96.0M | $73.7M | −23.3% | −17.48% |
| Nov 12, 2025Q1 FY26 | −$0.04 | −$0.12 | −200.0% | $90.2M | $77.4M | −14.2% | −8.56% |
| May 21, 2025Q3 FY25 | −$0.10 | −$0.02 | +80.0% | $111.8M | $59.6M | −46.7% | +1.80% |
Financial highlights
| 12 quarters | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $98.9M | $59.6M | $74.4M | $77.4M | $73.7M | $38.2M | |
| Gross profit | $41.3M | $23.5M | $23.3M | $35.6M | $26.3M | $11.5M | |
| Operating income | $15.2M | $933.2K | −$6.9M | $7.8M | $7.8M | −$6.5M | |
| Net income | $143.5K | −$1.3M | −$47.9M | −$7.3M | −$183.0M | −$12.3M | |
| Diluted EPS | $0.00 | −$0.02 | −$0.70 | −$0.12 | −$2.88 | −$0.19 | |
| Gross margin | 41.8% | 39.4% | 31.4% | 46.0% | 35.7% | 30.1% | |
| Operating margin | 15.4% | 1.6% | -9.3% | 10.0% | 10.6% | -17.0% |
Fiscal years (4-quarter sums)FY21 $206.7M · FY22 $328.5M · FY23 $419.4M · FY24 $464.8M · FY25 $325.5M
Revenue by geography · FY25
Balance sheet, Mar 31, 2026Cash & short-term investments $14.9M · Total debt $240.0M · Total assets $529.6M · Shareholders' equity $63.8M
Dividends
No dividends on record.
Ownership
Shares outstanding 63.23M · Float 44.33M · 70.1% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Jasper Lake Ventures One LLC | 8.71M | 12.13% | 13D | Jan 21, 2026 |
| Bioceres Group Limited | 6.27M | 10.00% | 13D | Oct 28, 2025 |
| Solel Partners LP | 4.58M | 7.24% | 13F | Aug 14, 2026 |
| Fourth Sail Capital LP | 4.33M | 6.82% | 13G | Jan 21, 2026 |
| Granosur Holding Limited | 3.72M | 5.83% | 13D | Jul 7, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- Corteva
Seeds, traits, crop protection and biological inputs for row crops
- FMC
Crop-protection biologicals, seed treatments and microbial crop inputs




